Survival Outcome Observation: An interesting... - CLL Support

CLL Support

22,532 members38,709 posts

Survival Outcome Observation

Smakwater profile image
7 Replies

An interesting publication offer relative to recent survival outcome data provided by CLL Society from ASCO 2022 -

cllsociety.org/2022/11/asco...

Video posting from above article -

youtu.be/ybKhm_WL8j8

Written by
Smakwater profile image
Smakwater
To view profiles and participate in discussions please or .
7 Replies
Smakwater profile image
Smakwater

It was unclear to me from the article to identify the authors exact academic locations that were polled, however, my perspective on academic centers is threefold. The first being research Universities with dedicated CLL research programs such as Ohio State U. The second is dedicated cancer centers like Sloan Kettering or Huntsman Cancer Institute which was mentioned. Thirdly would be Medical hospitals with specialized programs hosting clinical trials such as Willamette Valley Cancer institute being a member of the U.S. Oncology network.

AussieNeil profile image
AussieNeilAdministrator in reply to Smakwater

Thanks for clarifying what was meant by "Academic Centers" JM. Interesting to read that there's a survival advantage of nearly 3 years. I've said a few times previously that members of our community should see a significantly improved survival time too; they know to get up to date with their vaccinations, which should reduce their likelihood of early death due to infections and they also know which are the better treatments, the importance of finding a CLL specialist and much more.

Neil

Sushibruno profile image
Sushibruno in reply to AussieNeil

Neil "we can see the light at the end of the tunnel🙂, getting brighter 🙂."

Smakwater profile image
Smakwater in reply to AussieNeil

I may reach out to Dr. Koffman to acquire a more accurate definition of who these academic centers are.

Analeese profile image
Analeese in reply to Smakwater

My first guess would have been teaching hospitals. Your answer is far more through.

CLLerinOz profile image
CLLerinOzAdministratorVolunteer

Thanks for sharing this video presentation. Here's a link to the abstract which was also included in our earlier post about some of the other information presented at the ASCO 2022 conference:

meetings.asco.org/abstracts...

healthunlocked.com/cllsuppo...

spi3 profile image
spi3

Thank you for sharing the study compared 2004 - 2018 - I can only imagine what would be the results if the study was accomplished from 2018 to 2021 with all the new advances in CLL treatments!

You may also like...

cll-patient-survival-improves

discussion of old data at June ASCO:...

EHA 2022: Outcomes Following Treatment With a Covalent BTK and BCL2 Inhibitor

hibitor-among-patients-with-chronic-lymphocytic-leukemia-cll-small-lymphocytic-lymphoma-sll-a-real-w

New CLL survival milestones

thinking about CLL patients living 20 to 30 years after they start treatment.”...

Mode of Progression After Frontline Treatment Predicts Clinical Outcomes in Patients With CLL

000 patients from three German CLL Study Group clinical trials has identified that unfit patients...

Progression Free Survival

Hi. Can someone explain Progression Free Survival (PFS)? Here is example. I am 54 years old. I start